Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
APYX — Apyx Medical Corporation
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 6, 2026
REVENUE
$13.9M +11.2%
NET MARGIN
-23.4% -6.5 PTS
EPS
-$0.08 -53.8%
FREE CASH FLOW
-$3.6M -462.7%

No summary has been written for this call yet.